Stanley Druckenmiller Sells Nvidia Pivots to These 3 AI Infrastructure Stocks SpaceX Postpones Starship Launch Amid Plans for RecordBreaking Stock Market Debut Mercury Reaches 52 Billion Valuation in Latest Funding Round Defying Fintech Downturn Nvidia Stock Drops PostEarnings Why Sellers May Be Overlooking the LongTerm Picture RBIs 5 Billion FX Swap Oversubscribed Nearly Twofold Amid Rupee Defence BlueCollar Workers Emerge as Winners in AI Economy ATT CEO Says BKR Q1 2026 Earnings EPS Surges Past Estimates by 16 Yet Stock Slides 53 AIRO Q4 2025 Earnings EPS Misses Estimates Amid Operational Challenges Pixelworks Q1 2026 Earnings Stunning EPS Beat Overshadowed by Revenue Ambiguity FBRX Q1 2026 Earnings WiderthanExpected Loss Reflects PreRevenue Biotech Reality Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue VLN Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Uncertainties Research Solutions Inc RSSS Posts Small Gain as Stock Holds Between Support and Resistance FB Financial Corporation FBK Gains 154 as Regional Bank Sector Finds Footing Enova International ENVA Pulls Back 171 as Shares Approach Key Support Level Third Coast Bancshares TCBX Posts Modest Gains as Regional Bank Sentiment Shifts Swvl Holdings Corp SWVL Retreats 1066 as Key Support Levels Are Tested AXT Inc Shares Surge 157 Ahead of Anticipated Corporate Announcements BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops AGCO Corporation AGCO Gains Ground Technical Rally or Trend Shift EuroDry Ltd EDRY Q1 2026 Earnings EPS Misses Estimates by a Wide Margin as Costs Weigh DLHC Q1 2026 Earnings EPS Misses Estimates Amidst Limited Revenue Disclosure CTSH Q1 2026 Earnings EPS Beats Estimates as Stock Gains THO Q1 2026 Earnings Massive EPS Beat Drives Positive Market Response Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline SVM Q1 2026 Earnings Strong EPS Beat Highlights Silver and Cost Management Gains CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss